Watch Ticker

Apogee Therapeutics, Inc. Common Stock

Go to Apogee Therapeutics, Inc. Common Stock Website

$38.62

1.38 (3.69%)

Live

Previous Close

$37.24

Day Range

$36.58 - $38.92

Previous Day Range

$37.12 - $38.305

Market Cap

$2.2 billion USD

Day Vol.

329260

Previous Day Vol.

527335

Currency

USD

Primary Exchange

None

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with h...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Apogee Therapeutics - Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics reported positive 16-week data from its Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody for moderate-to-severe atopic dermatitis. The trial showed 71% reduction in EASI score and 66.9% of patients achieving EASI-75 response, with a favorable safety profile.

Related tickers: APGE.

Read Full Article

Apogee Therapeutics, Inc. - Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025

Apogee Therapeutics will report 16-week data from its Phase 2 APEX trial for APG777, a potential treatment for atopic dermatitis, on July 7, 2025, with a conference call and webcast to discuss the results.

Related tickers: APGE.

Read Full Article

Trending Tickers

Please sign in to view